Improved outcomes with allogeneic compared with autologous stem cell transplantation in aggressive T-cell lymphoma

Lymphoma
08/06/2020

McIlroy G, et al. Eur J Haematol 2020.

ABSTRACT

Peripheral T-cell lymphomas (PTCL) are a rare and aggressive subtype of non-Hodgkin lymphoma (NHL), comprising up to 10% of all newly diagnosed NHL in the UK. The use of hematopoietic stem cell transplantation (SCT) to improve survival is has gained recognition in the up-front and relapsed setting, although evidence is limited for patients with refractory disease.